Liu Xiaoxue, Li Quanxia, Du Xu, Zhao Xiaodong, Yin Zundong
Jinan Municipal Center for Disease Control and Prevention, No.2 Weiliu Road, Huaiyin District, Jinan 250021, China.
Licheng District Center for Disease Control and Prevention, Licheng District, Jinan 250199, China.
Vaccines (Basel). 2022 Jul 31;10(8):1225. doi: 10.3390/vaccines10081225.
Licheng District of Jinan Prefecture reported a school-based varicella outbreak. We conducted an investigation to analyze the epidemiology and scope of the outbreak, determine varicella vaccine coverage on the school campus, and estimate varicella vaccine effectiveness (VE).
In the epidemiological investigation, we determined the attack rate, the clinical manifestations of varicella cases, and histories of prior varicella disease and varicella vaccination. We tested students for presence of serum IgM antibodies, and we attempted to isolate the varicella virus from vesicular fluid samples. We used chi-square to compare incidences between classes and floors. VE was estimated using a retrospective cohort study.
There were 13 varicella cases in the outbreak. All were among fourth grade students - twelve in Class 7 and one in Class 6. The attack rate in the two classrooms was 14.3% (13/91). Clinical symptoms were rash (100%) and fever (46.15%). All cases were reported within one average incubation period, and the epidemic curve suggested common exposure. Six of the 13 cases previously received one dose of varicella vaccine with a median time between vaccination and infection of 9 years; the other seven cases had not been vaccinated. Varicella vaccine coverage with one or more doses was 81.31%; 2-dose coverage was 38.15%. The median age of receipt of dose 1 was 1.18 years, and median age for receiving dose 2 was 5.12 years. One-dose varicella VE was 73.2% (95% confidence interval: 37.0%, 88.6%), and two-dose VE was 100%.
Varicella vaccine coverage has been gradually increasing in recent years, as ≥1-dose and 2-dose coverage rates are higher in younger children than older children. High one-dose vaccination coverage limited the outbreak scope and led to the breakthrough cases being mild. Mild cases were difficult to detect in a timely manner. Varicella vaccine was highly effective, with 1-dose VE of 73% nine years after vaccination and 2-dose VE of 100%. We strongly recommended that all school students receive two doses of varicella vaccine.
济南市历城区报告了一起校内水痘暴发疫情。我们开展了一项调查,以分析此次疫情的流行病学特征和范围,确定校园内水痘疫苗接种率,并评估水痘疫苗效力(VE)。
在流行病学调查中,我们确定了发病率、水痘病例的临床表现、既往水痘病史和水痘疫苗接种史。我们检测了学生血清IgM抗体的存在情况,并尝试从水疱液样本中分离水痘病毒。我们使用卡方检验比较班级和楼层之间的发病率。通过回顾性队列研究评估疫苗效力。
此次疫情中有13例水痘病例。所有病例均为四年级学生,其中7班12例,6班1例。两个班级的发病率为14.3%(13/91)。临床症状为皮疹(100%)和发热(46.15%)。所有病例均在一个平均潜伏期内报告,流行曲线提示存在共同暴露。13例病例中有6例之前接种过一剂水痘疫苗,接种与感染之间的中位时间为9年;其他7例未接种过疫苗。一剂或多剂水痘疫苗接种率为81.31%;两剂接种率为38.15%。接种第一剂疫苗的中位年龄为1.18岁,接种第二剂疫苗的中位年龄为5.12岁。一剂水痘疫苗效力为73.2%(95%置信区间:37.0%,88.6%),两剂疫苗效力为100%。
近年来水痘疫苗接种率逐渐上升,因为年幼儿童的一剂和两剂接种率高于年长儿童。高剂量的一剂疫苗接种率限制了疫情范围,导致突破性病例症状较轻。轻症病例难以及时发现。水痘疫苗非常有效,接种一剂后9年的疫苗效力为73%,接种两剂的疫苗效力为100%。我们强烈建议所有在校学生接种两剂水痘疫苗。